AR240018A1
(es)
*
|
1987-10-07 |
1990-01-31 |
Merrell Pharma Inc |
Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
|
US4929605A
(en)
*
|
1987-10-07 |
1990-05-29 |
Merrell Dow Pharmaceuticals Inc. |
Pharmaceutical composition for piperidinoalkanol derivatives
|
CN1053570C
(zh)
|
1987-10-07 |
2000-06-21 |
默尔多药物公司 |
哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
|
US4908372A
(en)
*
|
1988-10-13 |
1990-03-13 |
Merrell Dow Pharmaceuticals Inc. |
Antihistaminic piperidinyl benzimidazoles
|
ZA90341B
(en)
*
|
1989-01-23 |
1990-10-31 |
Merrell Dow Pharma |
Liquid pharmaceutical composition for piperidinoalkanol derivatives
|
DE3917241A1
(de)
*
|
1989-05-26 |
1990-11-29 |
Schaper & Bruemmer Gmbh |
4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
|
US5182097A
(en)
*
|
1991-02-14 |
1993-01-26 |
Virginia Commonwealth University |
Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
US5190029A
(en)
*
|
1991-02-14 |
1993-03-02 |
Virginia Commonwealth University |
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
TW198008B
(fr)
*
|
1991-04-08 |
1993-01-11 |
Green Cross Corp |
|
HU211019B
(en)
*
|
1991-12-02 |
1995-09-28 |
Richter Gedeon Vegyeszet |
Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
|
KR100269756B1
(ko)
*
|
1992-02-13 |
2000-10-16 |
슈테펜엘.네스비트 |
피페리디닐티아시클릭유도체(Piperidinyl Thiacyclic Derivatives)
|
EP0635004B1
(fr)
*
|
1992-04-10 |
2002-07-17 |
Merrell Pharmaceuticals Inc. |
Derives de piperidine 4-diphenymethylique et leur procede de preparation
|
US5631375A
(en)
*
|
1992-04-10 |
1997-05-20 |
Merrell Pharmaceuticals, Inc. |
Process for piperidine derivatives
|
WO1993023047A1
(fr)
|
1992-05-11 |
1993-11-25 |
Merrell Dow Pharmaceuticals Inc. |
Utilisation de derives de terfenadine en tant qu'antihistaminiques chez un patient souffrant de troubles hepatiques
|
ATE363283T1
(de)
*
|
1992-08-03 |
2007-06-15 |
Sepracor Inc |
Terfenadin-carboxylat und die behandlung von hautreizung
|
US5654433A
(en)
*
|
1993-01-26 |
1997-08-05 |
Merrell Pharmaceuticals Inc. |
Process for piperidine derivatives
|
US20020007068A1
(en)
*
|
1999-07-16 |
2002-01-17 |
D'ambra Thomas E. |
Piperidine derivatives and process for their production
|
ATE254594T1
(de)
*
|
1993-06-24 |
2003-12-15 |
Albany Molecular Res Inc |
Verbindungen verwendbar als zwischenprodukte zur herstellung von piperidinderivate
|
US6147216A
(en)
*
|
1993-06-25 |
2000-11-14 |
Merrell Pharmaceuticals Inc. |
Intermediates useful for the preparation of antihistaminic piperidine derivatives
|
KR100333790B1
(ko)
|
1993-06-25 |
2002-11-04 |
메렐 파마슈티칼스 인크. |
항히스타민성4-디페닐메틸/디페닐메톡시피페리딘유도체제조용신규중간체
|
WO1995010278A1
(fr)
*
|
1993-10-15 |
1995-04-20 |
Hoechst Marion Roussel, Inc. |
Traitement des troubles allergiques par le carboxylate de terfenadine
|
PT725639E
(pt)
*
|
1993-10-25 |
2001-02-28 |
Merrell Pharma Inc |
Composicao farmaceutica estavel de terfenadina e ibuprofeno
|
KR100387459B1
(ko)
*
|
1994-05-16 |
2003-11-20 |
메렐 파마슈티칼스 인크. |
라세미성a-[4-(1,1-디메틸에틸)페닐]-4-(하이드록시디페닐메틸)-1-피페리딘부탄올및이의유도체화합물의광학분할법및이에유용한부분입체이성체염
|
CN101497581B
(zh)
*
|
1994-05-18 |
2012-07-11 |
安万特萨博Ⅱ有限公司 |
抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
|
US20030045722A1
(en)
*
|
1994-05-18 |
2003-03-06 |
Henton Daniel R. |
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
|
WO1995031437A1
(fr)
*
|
1994-05-18 |
1995-11-23 |
Hoechst Marrion Roussel, Inc. |
Procedes de preparation de formes anhydres et hydratees de derives de piperidine antihistaminiques, polymorphes et pseudomorphes de ces dernieres
|
AU693936B2
(en)
|
1994-08-25 |
1998-07-09 |
Merrell Pharmaceuticals Inc. |
Novel substituted piperidines useful for the treatment of allergic diseases
|
CN1090935C
(zh)
*
|
1995-02-28 |
2002-09-18 |
阿温蒂斯药物公司 |
哌啶子基烷醇化合物的药物组合物
|
WO1996035667A1
(fr)
*
|
1995-05-08 |
1996-11-14 |
Hoescht Marion Roussel, Inc. |
Derives butanol d'alpha-(alkylphenyl substitue)-4-(hydroxydiphenylmethyl)-1-piperidine, leur preparation et leur utilisation en tant qu'agents antihistaminiques, antiallergiques et dilatateurs bronchiques
|
US5574045A
(en)
*
|
1995-06-06 |
1996-11-12 |
Hoechst Marion Roussel, Inc. |
Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
|
US5906747A
(en)
*
|
1995-11-13 |
1999-05-25 |
Biosepra Inc. |
Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
|
US6211199B1
(en)
|
1995-11-17 |
2001-04-03 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
|
US6423704B2
(en)
|
1995-12-20 |
2002-07-23 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
|
US6194406B1
(en)
|
1995-12-20 |
2001-02-27 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
|
US6153754A
(en)
*
|
1995-12-21 |
2000-11-28 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US6201124B1
(en)
*
|
1995-12-21 |
2001-03-13 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US5998439A
(en)
*
|
1996-02-21 |
1999-12-07 |
Hoescht Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
|
US5922737A
(en)
*
|
1996-02-21 |
1999-07-13 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
|
US5932571A
(en)
*
|
1996-02-21 |
1999-08-03 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
|
US5925761A
(en)
*
|
1997-02-04 |
1999-07-20 |
Sepracor Inc. |
Synthesis of terfenadine and derivatives
|
ATE260983T1
(de)
*
|
1997-03-11 |
2004-03-15 |
Aventis Pharma Inc |
Verfahren zur herstellung von 4-(4-(4- (hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl - alpha,alpha-dimenthylphenylessigsäure und phosphorylierter derivate
|
US6451815B1
(en)
|
1997-08-14 |
2002-09-17 |
Aventis Pharmaceuticals Inc. |
Method of enhancing bioavailability of fexofenadine and its derivatives
|
NZ501248A
(en)
*
|
1997-08-26 |
2001-06-29 |
Aventis Pharma Inc |
Pharmaceutical composition for combination of piperidinoalkanol-decongestant
|
ATE243191T1
(de)
*
|
1997-12-17 |
2003-07-15 |
Aventis Pharma Gmbh |
Verfahren zur alkylierung von alkyl- oder benzylcyanderivaten in gegenwart von trialkylaminen oder -phosphinen
|
IL136461A0
(en)
*
|
1997-12-23 |
2001-06-14 |
Schering Corp |
Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
|
US6194431B1
(en)
|
1998-04-14 |
2001-02-27 |
Paul D. Rubin |
Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
|
CN1246312C
(zh)
*
|
1998-07-02 |
2006-03-22 |
阿旺蒂斯制药公司 |
新的抗组胺哌啶衍生物及制备其的中间体
|
US6683094B2
(en)
|
1998-07-02 |
2004-01-27 |
Aventis Pharmaceuticals Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
AU2007200674C1
(en)
*
|
1998-07-02 |
2011-02-24 |
Aventisub Llc |
Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
US6930197B2
(en)
|
1998-07-02 |
2005-08-16 |
Aventis Pharmaceuticals Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
GB9822170D0
(en)
*
|
1998-10-13 |
1998-12-02 |
Danbioyst Uk Ltd |
Novel formulations of fexofenadine
|
IN191492B
(fr)
*
|
1999-05-25 |
2003-12-06 |
Ranbaxy Lab Ltd |
|
US6613906B1
(en)
*
|
2000-06-06 |
2003-09-02 |
Geneva Pharmaceuticals, Inc. |
Crystal modification
|
US6613907B2
(en)
|
2000-11-08 |
2003-09-02 |
Amr Technology, Inc. |
Process for the production of piperidine derivatives with microorganisms
|
CH695216A5
(de)
*
|
2001-02-23 |
2006-01-31 |
Cilag Ag |
Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
|
US20030021849A1
(en)
*
|
2001-04-09 |
2003-01-30 |
Ben-Zion Dolitzky |
Polymorphs of fexofenadine hydrochloride
|
EP1392303A4
(fr)
*
|
2001-04-09 |
2005-01-26 |
Teva Pharma |
Polymorphes de chlorhydrate de fexofenadine
|
US7700779B2
(en)
*
|
2001-06-18 |
2010-04-20 |
Dr. Reddy's Laboratories Limited |
Crystalline forms of fexofenadine and its hydrochloride
|
JP2005507374A
(ja)
|
2001-06-18 |
2005-03-17 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
新規な型の4−[4−[4−(ヒドロキシジフェニルメチル)−1−ピペリジニル]−1−ヒドロキシブチル]−α,α−ジメチルベンゼン酢酸及びその塩酸塩
|
US20030158227A1
(en)
*
|
2001-11-08 |
2003-08-21 |
Barnaba Krochmal |
Polymorphs of fexofenadine base
|
EP1453509A2
(fr)
*
|
2001-11-08 |
2004-09-08 |
Teva Pharmaceutical Industries Ltd. |
Polymorphes a base fexofenadine
|
US6723348B2
(en)
*
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
JP2005532356A
(ja)
*
|
2002-06-10 |
2005-10-27 |
テバ ファーマシューティカル インダストリーズ リミティド |
塩酸フェキソフェナジンの多型体xvi
|
EP1575893A1
(fr)
*
|
2002-12-16 |
2005-09-21 |
Ranbaxy Laboratories Limited |
Procede de preparation de la fexofenadine
|
CA2514610A1
(fr)
*
|
2003-01-31 |
2004-08-12 |
Ranbaxy Laboratories Limited |
Procede de preparation de fexofenadine
|
US20050065183A1
(en)
*
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
GB0319935D0
(en)
*
|
2003-08-26 |
2003-09-24 |
Cipla Ltd |
Polymorphs
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
MXPA06012281A
(es)
*
|
2004-04-26 |
2007-07-18 |
Teva Pharma |
Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion.
|
WO2006008567A1
(fr)
*
|
2004-06-18 |
2006-01-26 |
Wockhardt Limited |
Compositions pharmaceutiques a base de composes piperidinoalcanols
|
ITMI20041568A1
(it)
*
|
2004-07-30 |
2004-10-30 |
Dipharma Spa |
"polimorfi di fexofenadina base"
|
US7498345B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US7498443B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of carebastine
|
WO2006037042A1
(fr)
*
|
2004-09-28 |
2006-04-06 |
Teva Pharmaceutical Industries Ltd. |
Forme de cristal de fexofenadine et ses processus de preparation
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
KR20070104884A
(ko)
|
2004-11-24 |
2007-10-29 |
메드포인트 헬쓰케어 인크. |
아젤라스틴을 포함하는 조성물 및 이의 사용 방법
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
JP2008120684A
(ja)
*
|
2005-03-07 |
2008-05-29 |
Kumamoto Univ |
抗アレルギー薬
|
JP5133244B2
(ja)
*
|
2005-08-05 |
2013-01-30 |
ルピン・リミテッド |
フェキソフェナジンの経口用医薬懸濁組成物
|
US20070088065A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jie Du |
Metaxalone products, method of manufacture, and method of use
|
US20080292584A1
(en)
*
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
WO2007049303A2
(fr)
*
|
2005-10-28 |
2007-05-03 |
Ind-Swift Laboratories Limited |
Procede ameliore pour preparer de la fexofenadine a purete elevee
|
ZA200804550B
(en)
|
2005-11-09 |
2009-08-26 |
Combinatorx Inc |
Methods, compositions, and kits for the treatment of medical conditions
|
DOP2006000274A
(es)
*
|
2005-12-14 |
2007-10-15 |
Sanofi Aventis Us Llc |
Formulación de suspensión de fexofenadina
|
CN100443470C
(zh)
*
|
2006-07-21 |
2008-12-17 |
杭州保灵有限公司 |
一种依巴斯汀的制备方法
|
ITMI20061491A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
ITMI20061492A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
KR101519028B1
(ko)
|
2007-04-13 |
2015-05-11 |
써던 리서취 인스티튜트 |
항혈관형성제 및 사용방법
|
ITMI20070987A1
(it)
*
|
2007-05-16 |
2008-11-17 |
Dipharma Francis Srl |
Procedimento per la preparazione di composti chetonici
|
US20090076080A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fexofenadine
|
EP2105134A1
(fr)
|
2008-03-24 |
2009-09-30 |
Ranbaxy Laboratories Limited |
Hydrochlorure de fexofenadine amorphe stable
|
WO2009145921A1
(fr)
*
|
2008-05-30 |
2009-12-03 |
Fairfield Clinical Trials, Llc |
Procédé et composition pour une inflammation et une décoloration de la peau
|
WO2010021681A2
(fr)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions et procédés pour le traitement de maladies virales
|
CN101585805B
(zh)
*
|
2009-06-06 |
2011-07-06 |
浙江大学宁波理工学院 |
一种抗过敏药物非索非那定盐酸盐的制备方法
|
EP2289867A3
(fr)
|
2009-08-19 |
2012-04-25 |
Jubilant Organosys Limited |
Procédé de production d'acide acétique 4-(4-halo-1-oxybutyl)-alpha, alpha-dimethylbenzene ou esthers d'alkyle associés
|
CN101671292B
(zh)
*
|
2009-10-10 |
2011-09-07 |
浙江大学宁波理工学院 |
盐酸非索非那定的合成方法
|
US20110130711A1
(en)
*
|
2009-11-19 |
2011-06-02 |
Follica, Inc. |
Hair growth treatment
|
EP2371817A1
(fr)
*
|
2010-04-01 |
2011-10-05 |
Arevipharma GmbH |
Procédé pour la préparation de 1-[4-(1,1-diméthyléthyl)phényl]-4-[4-(diphénylméthoxy)-1-pipéridinyl]-1-butanone et de sels d'addition acides correspondant
|
US9216955B2
(en)
|
2010-06-15 |
2015-12-22 |
Chemelectiva S.R.L. |
Polymorphic form of Fexofenadine hydrochloride, intermediates and process for its preparation
|
JP5925301B2
(ja)
|
2011-05-23 |
2016-05-25 |
サノフイ |
N−アルキル基を含有するジュウテリウム化化合物の製造方法
|
WO2013047725A1
(fr)
|
2011-09-29 |
2013-04-04 |
塩野義製薬株式会社 |
Produit pharmaceutique thérapeutique contre la rhinite allergique comportant un antagoniste de pgd2 et un antagoniste d'histamine
|
EP2578570A1
(fr)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
|
EP2641900A1
(fr)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
|
CN102659667B
(zh)
*
|
2012-04-20 |
2013-08-14 |
浙江启明药业有限公司 |
一种非索非那定关键中间体的合成方法
|
CN103333100B
(zh)
*
|
2013-06-06 |
2016-04-06 |
池州东升药业有限公司 |
一种盐酸非索非那定的合成工艺
|
ITMI20131652A1
(it)
|
2013-10-07 |
2015-04-08 |
Dipharma Francis Srl |
Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
|
CN104557671B
(zh)
*
|
2013-10-10 |
2018-04-13 |
池州东升药业有限公司 |
一种非索非那定及中间体的合成方法
|
EP2949321A1
(fr)
|
2014-05-26 |
2015-12-02 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Formulations multicouche de fexofénadine et de montélukast
|
WO2016116555A1
(fr)
|
2015-01-22 |
2016-07-28 |
Sanofi-Aventis Deutschland Gmbh |
Procédé pour la production de 2-[4-(cyclopropanecarbonyl)phényl]-2-méthyl-propanenitrile
|
CA3002425C
(fr)
|
2015-10-22 |
2023-10-17 |
Sanofi-Aventis Deutschland Gmbh |
Procede de preparation de fexofenadine et d'intermediaires utilises dans celle-ci
|
GB202212656D0
(en)
|
2022-08-31 |
2022-10-12 |
Novumgen Ltd |
An orodispersible tablet of fecofenadine and it process of preparation
|
WO2024153354A1
(fr)
|
2023-01-20 |
2024-07-25 |
Opella Healthcare Group Sas |
Formulations de fexofénadine sans parabène
|